AmerisourceBergen Corporation, commonly referred to as Amerisource, is a leading global healthcare solutions provider headquartered in the United States. Founded in 2001, the company has established itself as a key player in the pharmaceutical distribution industry, serving healthcare providers across North America and beyond. Amerisource focuses on the distribution of pharmaceutical products, including specialty drugs and biologics, while also offering innovative services that enhance patient care. Its commitment to improving healthcare delivery is evident through its unique approach to supply chain management and patient support services. With a strong market position, Amerisource has achieved notable milestones, including strategic partnerships and acquisitions that have expanded its operational reach. The company continues to be recognised for its dedication to quality and efficiency in the healthcare sector.
How does Amerisource's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Maritime Transport industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Amerisource's score of 11 is lower than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2019, Amerisource reported total carbon emissions of approximately 33,597,500 kg CO2e for Scope 1 and about 86,713,900 kg CO2e for Scope 2 emissions. Additionally, Scope 3 emissions from business travel amounted to around 28,356,600 kg CO2e. Amerisource has set ambitious climate commitments, aiming for net zero emissions by 2050 for both Scope 1 and Scope 2 emissions. This long-term target reflects the company's dedication to reducing its carbon footprint and addressing climate change. The commitment was established in 2023, signalling a proactive approach to sustainability and environmental responsibility. As of now, there are no specific reduction targets disclosed under the Science Based Targets initiative (SBTi), but the overarching goal of achieving net zero emissions demonstrates a significant commitment to climate action.
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | |
|---|---|
| Scope 1 | 33,597,500 |
| Scope 2 | 86,713,900 |
| Scope 3 | 28,356,600 |
Their carbon footprint includes suppliers and value chain emissions, with Scope 3 emissions accounting for 19% of total emissions under the GHG Protocol, with "Business Travel" representing nearly all of their reported Scope 3 footprint.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Amerisource has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
